A critical breakthrough in cancer investigation is emerging with the use of mini-antibodies to reactivate damaged p53. This vital tumor suppressor protein is frequently lost in many kinds of cancer, resulting https://hubwebsites.com/story23506573/mini-antibodies-revive-the-p53-protein-new-new-hope-for-malignant-therapy